Edition:
United States

Spherix Inc (SPEX.PH)

SPEX.PH on Philadelphia Stock Exchange

1.00USD
20 Jun 2017
Change (% chg)

-- (--)
Prev Close
$1.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,770
52-wk High
$2.42
52-wk Low
$1.00

Latest Key Developments (Source: Significant Developments)

Spherix announces definitive terms reached to acquire controlling interest in Hoth Therapeutics
Tuesday, 20 Jun 2017 08:00am EDT 

June 20 (Reuters) - Spherix Inc :Spherix Inc. announces definitive terms reached to acquire controlling interest in Hoth therapeutics, a biopharmaceutical company developing its Biolexa platform to treat skin illness such as eczema..Spherix Inc - Believe investment is "an accretive value to our shareholders".  Full Article

Spherix issues shareholder update
Monday, 8 Aug 2016 12:00pm EDT 

Spherix Inc : Spherix issues shareholder update . Spherix Inc - Working with Equitable IP, there are several additional patent suits planned . Spherix Inc says "Anticipate 2-3 more suits before end of august and additional suits filed in September" .Spherix Inc - Before September 1, equitable intends to "continue monetization effort by filing more suits on valuable patents formerly owned by Nortel".  Full Article

Spherix prices stock offering at $1.57/shr for $2.5 mln gross proceeds
Wednesday, 3 Aug 2016 09:38am EDT 

Spherix Inc : Spherix announces pricing of underwritten public offering of common stock . Says public offering priced at $1.57 per share .Gross proceeds to Spherix from offering are expected to be $2.5 million.  Full Article

Spherix executes second license agreement with RPX Corp
Tuesday, 24 May 2016 08:00am EDT 

Spherix Inc : Announced a second licensing agreement with RPX Corporation .Spherix executes second license agreement with RPX Corporation.  Full Article

Spherix Inc announces collaborative agreement to monetize patents
Tuesday, 8 Mar 2016 09:00am EST 

Spherix Inc:Spherix announces collaborative agreement to monetize patents.Says equitable and the company have executed a collaborative agreement to monetize a portion of spherix's patent portfolio.  Full Article

More From Around the Web

BRIEF-Spherix announces definitive terms reached to acquire controlling interest in Hoth Therapeutics

* Spherix Inc. announces definitive terms reached to acquire controlling interest in Hoth therapeutics, a biopharmaceutical company developing its Biolexa platform to treat skin illness such as eczema.

No consensus analysis data available.